Cerebrospinal-fluid orexin levels and daytime somnolence in frontotemporal dementia

Journal of Neurology

Volumn 261, Issue 9, 2014, Pages 1832-1836

  Liguori, C ^a   Romigi, A ^a   Mercuri, N B ^a,b   Nuccetelli, M ^a   Izzi, F ^a   Albanese, M ^a   Sancesario, G ^a,b   Martorana, A ^a   Sancesario, G M ^a   Bernardini, S ^a   Marciani, M G ^a,b   Placidi, F ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

Author keywords

CSF; Daytime sleepiness; ESS; Frontotemporal dementia; Orexin

Indexed keywords

NEUROPEPTIDE; OREXINS; SIGNAL PEPTIDE;

AGED; CASE CONTROL STUDY; CEREBROSPINAL FLUID; COMPLICATION; DISORDERS OF EXCESSIVE SOMNOLENCE; FEMALE; FRONTOTEMPORAL DEMENTIA; HUMAN; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; SLEEP; SLEEP STAGE; STATISTICS;

AGED; CASE-CONTROL STUDIES; DISORDERS OF EXCESSIVE SOMNOLENCE; FEMALE; FRONTOTEMPORAL DEMENTIA; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; NEUROPEPTIDES; SLEEP; SLEEP STAGES; STATISTICS AS TOPIC;

EID: 84939887276     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-014-7455-z     Document Type: Article

References (23)

1. Ratnavalli E, Brayne C, Dawson K, Hodges JR (2002) The prevalence of frontotemporal dementia. Neurology 58(11):1615–1621
2. Neary D, Snowden J, Mann D (2005) Frontotemporal dementia. Lancet Neurol 4(11):771–780
3. Chare L, Hodges JR, Leyton CE, McGinley C, Tan RH, Kril JJ, Halliday GM (2014) New criteria for frontotemporal dementia syndromes: clinical and pathological diagnostic implications. J Neurol Neurosurg Psychiatry 85(8):865–870
4. Bonakis A, Economou NT, Paparrigopoulos T, Bonanni E, Maestri M, Carnicelli L et al (2014) Sleep in frontotemporal dementia is equally or possibly more disrupted, and at an earlier stage, when compared to sleep in Alzheimer’s disease. J Alzheimers Dis 38(1):85–91
5. Kundermann B, Thum A, Rocamora R, Haag A, Krieg JC, Hemmeter U (2011) Comparison of polysomnographic variables and their relationship to cognitive impairment in patients with Alzheimer’s disease and frontotemporal dementia. J Psychiatr Res 45(12):1585–1592
6. Anderson KN, Hatfield C, Kipps C, Hastings M, Hodges JR (2009) Disrupted sleep and circadian patterns in frontotemporal dementia. Eur J Neurol 16(3):317–323
7. Harper DG, Stopa EG, McKee AC, Satlin A, Harlan PC, Goldstein R, Volicer L (2001) Differential circadian rhythm disturbances in men with Alzheimer disease and frontotemporal degeneration. Arch Gen Psychiatry 58(4):353–360
8. Kanbayashi T, Sagawa Y, Takemura F, Ito SU, Tsutsui K, Hishikawa Y, Nishino S (2011) The pathophysiologic basis of secondary narcolepsy and hypersomnia. Curr Neurol Neurosci Rep 11(2):235–241
9. Kilduff TS, Peyron C (2000) The hypocretin/orexin ligand-receptor system: implications for sleep and sleep disorders. Trends Neurosci 23(8):359–365
10. Kirchgessner AL, Liu M (1999) Orexin synthesis and response in the gut. Neuron 24(4):941–951
11. Çoban A, Bilgiç B, Lohmann E, Küçükali Cİ, Benbir G, Karadeniz D et al (2013) Reduced orexin-A levels in frontotemporal dementia: possible association with sleep disturbance. Am J Alzheimers Dis Other Demen 28(6):606–611
12. Dalal MA, Schuld A, Haack M, Uhr M, Geisler P, Eisensehr I et al (2001) Normal plasma levels of orexin A (hypocretin-1) in narcoleptic patients. Neurology 56(12):1749–1751
13. Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ (1989) The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 28(2):193–213
14. Vignatelli L, Plazzi G, Barbato A, Ferini-Strambi L, Manni R, Pompei F et al (2003) Italian version of the Epworth sleepiness scale: external validity. Neurol Sci 23(6):295–300
15. Johns MW (1991) A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14(6):540–545
16. Sancesario GM, Esposito Z, Nuccetelli M, Bernardini S, Sorge R, Martorana A et al (2010) Abeta1-42 detection in CSF of Alzheimer’s disease is influenced by temperature: indication of reversible Abeta1-42 aggregation? Exp Neurol 223(2):371–376
17. Liguori C, Placidi F, Albanese M, Nuccetelli M, Izzi F, Marciani MG et al (2014) CSF beta-amyloid levels are altered in narcolepsy: a link with the inflammatory hypothesis? J Sleep Res 23(4):420–424
18. Merlino G, Piani A, Gigli GL, Cancelli I, Rinaldi A, Baroselli A et al (2010) Daytime sleepiness is associated with dementia and cognitive decline in older Italian adults: a population-based study. Sleep Med 11(4):372–377
19. Saper CB, Chou TC, Scammell TE (2001) The sleep switch: hypothalamic control of sleep and wakefulness. Trends Neurosci 24(12):726–731
20. Piguet O, Petersén A, Yin Ka Lam B, Gabery S, Murphy K, Hodges JR, Halliday GM (2011) Eating and hypothalamus changes in behavioral-variant frontotemporal dementia. Ann Neurol 69(2):312–319
21. Engelborghs S, Maertens K, Vloeberghs E, Aerts T, Somers N, Mariën P, De Deyn PP (2006) Neuropsychological and behavioural correlates of CSF biomarkers in dementia. Neurochem Int 48(4):286–295
22. Grossman M, Farmer J, Leight S, Work M, Moore P, Van Deerlin V et al (2005) Cerebrospinal fluid profile in frontotemporal dementia and Alzheimer’s disease. Ann Neurol 57(5):721–729
23. Kapaki E, Paraskevas GP, Papageorgiou SG, Bonakis A, Kalfakis N, Zalonis I, Vassilopoulos D (2008) Diagnostic value of CSF biomarker profile in frontotemporal lobar degeneration. Alzheimer Dis Assoc Disord 22(1):47–53